Why is Aarey Drugs falling/rising?

As of 04-Aug, Aarey Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 68.60, which reflects a rise of 1.65 or 2.46%. The stock has shown strong performance recently, gaining 8.53% over the last four days and outperforming its sector by 1.46% today. It has also been trading above its moving averages across various time frames, indicating positive momentum. However, despite a 36.41% return over the past year, the company has faced challenges with a significant drop in profits of 21.3%, and its latest financials show a decline in net sales and operating losses, which could raise concerns among investors. In the broader market context, Aarey Drugs has outperformed the Sensex, which has only increased by 0.16% over the past week, while Aarey Drugs has risen by 6.36% in the same period. This strong short-term performance relative to the benchmark suggests that investor sentiment remains positive despite the company's underlying financial issues. The stock's attractive valuation compared to peers may also contribute to its rising price, although the weak long-term fundamentals and declining profitability metrics could temper enthusiasm moving forward.